Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (FY)Oct 31, 2025 | (Q4)Oct 31, 2025 | (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 65.81%156.98M | -5.94%-114.53M | -15.12%-104.92M | 13.44%207.84M | 52.28%168.58M | -70.58%94.67M | -91.81%-108.11M | -1,109.68%-91.14M | -3.85%183.22M | -43.26%110.7M |
| Net income from continuing operations | 312.15%241.92M | -130.29%-12.49M | 1,102.23%399.82M | 57.92%-22.88M | -100.95%-122.53M | -350.85%-114.03M | 1,190.36%41.23M | -169.62%-39.89M | -86.38%-54.39M | -7.71%-60.98M |
| Operating gains losses | -7,163.06%-344.12M | 71.95%-5.24M | -2,941.14%-409.69M | 58.31%29.6M | 385.89%39.08M | -150.66%-4.74M | -676.21%-18.68M | 186.08%14.42M | -33.43%18.7M | -161.58%-13.67M |
| Depreciation and amortization | 15.74%256.8M | 11.26%68.48M | 13.11%62.67M | 14.49%62.68M | 25.52%62.97M | 19.06%221.87M | 26.29%61.55M | 3.09%55.41M | 28.03%54.75M | 22.03%50.16M |
| Asset impairment expenditure | --0 | --0 | --0 | --0 | --0 | ---3.11M | --0 | --0 | --0 | ---3.11M |
| Remuneration paid in stock | 471.74%171K | -54.00%23K | 0.00%49K | 0.00%50K | 125.13%49K | -119.41%-46K | -21.88%50K | -19.67%49K | -10.71%50K | -448.21%-195K |
| Deferred tax | -91.61%227K | -95.37%124K | --0 | 101.38%4K | 121.38%99K | 3,083.53%2.71M | 3,140.91%2.68M | 23.54%782K | -82.91%-289K | -53.31%-463K |
| Other non cashItems | -202.64%-15.88M | 18.35%-8.4M | 118.53%279K | -260.16%-17.47M | 9.06%11.83M | -72.99%15.48M | -142.54%-10.29M | -113.46%-1.51M | 3.68%10.91M | -4.98%10.85M |
| Change In working capital | 176.20%17.87M | 14.96%-157.03M | -31.27%-158.05M | 1.55%155.86M | 38.23%177.09M | -125.03%-23.45M | -36.08%-184.65M | -5.87%-120.4M | 10.85%153.49M | -37.40%128.11M |
| -Change in other working capital | 176.20%17.87M | 14.96%-157.03M | -31.27%-158.05M | 1.55%155.86M | 38.23%177.09M | -125.03%-23.45M | -36.08%-184.65M | -5.87%-120.4M | 10.85%153.49M | -37.40%128.11M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 65.81%156.98M | -5.94%-114.53M | -15.12%-104.92M | 13.44%207.84M | 52.28%168.58M | -70.58%94.67M | -91.81%-108.11M | -1,109.68%-91.14M | -3.85%183.22M | -43.26%110.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 67.55%-10.21M | -151.54%-29.83M | 206.37%31.2M | 38.20%-19.31M | 126.91%7.73M | -296.36%-31.45M | 314.54%57.87M | -609.21%-29.33M | -329.28%-31.25M | -174.26%-28.75M |
| Net PPE purchase and sale | 88.66%-5.79M | 8.74%62.24M | -3.12%-30.25M | 50.04%-14.9M | 53.46%-22.88M | 11.27%-51.08M | 337.01%57.23M | -107.48%-29.33M | -238.80%-29.82M | -369.03%-49.16M |
| Net business purchase and sale | --0 | --0 | --0 | --0 | ---- | -57.57%20.41M | --0 | --0 | --0 | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --20.41M |
| Net other investing changes | -462.88%-4.41M | -14,440.34%-92.07M | --61.45M | -209.47%-4.41M | --30.62M | -151.48%-784K | --642K | ---- | -193.63%-1.43M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 67.55%-10.21M | -151.54%-29.83M | 206.37%31.2M | 38.20%-19.31M | 126.91%7.73M | -296.36%-31.45M | 314.54%57.87M | -609.21%-29.33M | -329.28%-31.25M | -174.26%-28.75M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -1.20%-243.19M | 4.04%-49.43M | -110.35%-100.22M | 41.29%-45.79M | 24.39%-47.75M | -18.36%-240.29M | 45.23%-51.51M | -19.19%-47.65M | -171.75%-77.99M | -56.67%-63.15M |
| Net issuance payments of debt | 10.49%-216.87M | 35.34%-33.61M | -86.16%-89.82M | 41.07%-46.25M | 25.77%-47.18M | -18.56%-242.28M | 44.94%-51.98M | -19.41%-48.25M | -169.86%-78.48M | -57.11%-63.56M |
| Net common stock issuance | -3.07%1.93M | -5.08%448K | -13.25%524K | -7.03%463K | 18.84%492K | 30.28%1.99M | 28.61%472K | 39.49%604K | 29.35%498K | 21.41%414K |
| Net preferred stock issuance | ---16.27M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---11.98M | --0 | ---10.93M | ---- | ---1.06M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -1.20%-243.19M | 4.04%-49.43M | -110.35%-100.22M | 41.29%-45.79M | 24.39%-47.75M | -18.36%-240.29M | 45.23%-51.51M | -19.19%-47.65M | -171.75%-77.99M | -56.67%-63.15M |
| Net cash flow | ||||||||||
| Beginning cash position | -40.24%260.34M | -1.31%357.15M | 0.70%532.61M | -14.10%389.36M | -40.24%260.34M | 35.07%435.65M | -36.58%361.89M | -15.18%528.89M | -3.08%453.29M | 35.07%435.65M |
| Current changes in cash | 45.55%-96.42M | -90.47%-193.79M | -3.46%-173.94M | 92.94%142.74M | 583.61%128.57M | -259.82%-177.07M | 25.43%-101.74M | -225.53%-168.12M | -52.14%73.98M | -86.97%18.81M |
| Effect of exchange rate changes | -43.09%1M | 723.28%1.56M | -235.77%-1.52M | -68.21%514K | 138.78%453K | -24.12%1.76M | -87.39%189K | 184.54%1.12M | 27.52%1.62M | -233.18%-1.17M |
| End cash Position | -36.65%164.92M | -36.65%164.92M | -1.31%357.15M | 0.70%532.61M | -14.10%389.36M | -40.24%260.34M | -40.24%260.34M | -36.58%361.89M | -15.18%528.89M | -3.08%453.29M |
| Free cash from | 234.68%59.12M | -4.82%-144.36M | -11.60%-135.16M | 25.78%192.94M | 136.74%145.7M | -116.62%-43.9M | -71.06%-137.72M | -458.84%-121.11M | -15.60%153.4M | -66.66%61.54M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.